المؤلفون: Joost H van den Berg, Raquel Gomez-Eerland, Samira Michels, Maaike van Zon, Renate de Boer, Noor A M Bakker, Marit M van Buuren, Henk Mallo, Matthias Karger, Joris A van der Hage, Loes M Pronk, Marnix H Geukes Foppen, Bastiaan Nuijen, Ton N Schumacher

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

وصف الملف: electronic resource

العلاقة: https://jitc.bmj.com/content/8/2/e000848.fullTest; https://doaj.org/toc/2051-1426Test

الوصول الحر: https://doaj.org/article/dcfa2791fafa4572a3dce6276ee8be68Test

المؤلفون: Maartje W. Rohaan, Troels H. Borch, Joost H. van den Berg, Özcan Met, Rob Kessels, Marnix H. Geukes Foppen, Joachim Stoltenborg Granhøj, Bastiaan Nuijen, Cynthia Nijenhuis, Inge Jedema, Maaike van Zon, Saskia Scheij, Jos H. Beijnen, Marten Hansen, Carlijn Voermans, Inge M. Noringriis, Tine J. Monberg, Rikke B. Holmstroem, Lidwina D.V. Wever, Marloes van Dijk, Lindsay G. Grijpink-Ongering, Ludy H.M. Valkenet, Alejandro Torres Acosta, Matthias Karger, Jessica S.W. Borgers, Renske M.T. ten Ham, Valesca P. Retèl, Wim H. van Harten, Ferry Lalezari, Harm van Tinteren, Astrid A.M. van der Veldt, Geke A.P. Hospers, Marion A.M. Stevense-den Boer, Karijn P.M. Suijkerbuijk, Maureen J.B. Aarts, Djura Piersma, Alfons J.M. van den Eertwegh, Jan-Willem B. de Groot, Gerard Vreugdenhil, Ellen Kapiteijn, Marye J. Boers-Sonderen, W. Edward Fiets, Franchette W.P.J. van den Berkmortel, Eva Ellebaek, Lisbet R. Hölmich, Alexander C.J. van Akkooi, Winan J. van Houdt, Michel W.J.M. Wouters, Johannes V. van Thienen, Christian U. Blank, Aafke Meerveld-Eggink, Sebastian Klobuch, Sofie Wilgenhof, Ton N. Schumacher, Marco Donia, Inge Marie Svane, John B.A.G. Haanen

المساهمون: Guided Treatment in Optimal Selected Cancer Patients (GUTS), Medical Biochemistry, CCA - Cancer Treatment and Quality of Life, AII - Cancer immunology, Landsteiner Laboratory, General Internal Medicine, Health Technology & Services Research, Health Technology Assessment (HTA), Medical Oncology, Erasmus MC other, Surgery, Interne Geneeskunde, MUMC+: MA Medische Oncologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy

المصدر: New England Journal of Medicine, 387(23), 2113-2125. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 387, 2113-2125
New England journal of medicine, 387(23), 2113-2125. Massachussetts Medical Society
Rohaan, M W, Borch, T H, Van Den Berg, J H, Met, Ö, Kessels, R, Geukes Foppen, M H, Stoltenborg Granhøj, J, Nuijen, B, Nijenhuis, C, Jedema, I, Van Zon, M, Scheij, S, Beijnen, J H, Hansen, M, Voermans, C, Noringriis, I M, Monberg, T J, Holmstroem, R B, Wever, L D V, Van Dijk, M, Grijpink-Ongering, L G, Valkenet, L H M, Torres Acosta, A, Karger, M, Borgers, J S W, Ten Ham, R M T, Retèl, V P, Van Harten, W H, Lalezari, F, Van Tinteren, H, Van Der Veldt, A A M, Hospers, G A P, Stevense-Den Boer, M A M, Suijkerbuijk, K P M, Aarts, M J B, Piersma, D, Van Den Eertwegh, A J M, De Groot, J W B, Vreugdenhil, G, Kapiteijn, E, Boers-Sonderen, M J, Fiets, W E, Van Den Berkmortel, F W P J, Ellebaek, E, Hölmich, L R, Van Akkooi, A C J, Van Houdt, W J, Wouters, M W J M, Van Thienen, J V, Blank, C U, Meerveld-Eggink, A, Klobuch, S, Wilgenhof, S, Schumacher, T N, Donia, M, Svane, I M & Haanen, J B A G 2022, ' Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma. ', New England Journal of Medicine, vol. 387, no. 23, pp. 2113-2125 . https://doi.org/10.1056/NEJMoa2210233Test
The New England journal of medicine, 387(23), 2113-2125. Massachussetts Medical Society
New England Journal of Medicine, 387(23), 2113-2125. MASSACHUSETTS MEDICAL SOCIETY
The New England Journal of Medicine, 387, 23, pp. 2113-2125

مصطلحات موضوعية: Adoptive, Cell- and Tissue-Based Therapy, Outcomes, Dermatology, Metastatic melanoma, Guidelines, Immunotherapy, Adoptive, Healthcare improvement science Radboud Institute for Health Sciences [Radboudumc 18], Lymphocytes, Tumor-Infiltrating, SDG 3 - Good Health and Well-being, Adoption, Humans, Melanoma/drug therapy, Lymphocytes, Tumor-Infiltrating, Melanoma, Skin Cancer, Treatments in Oncology, Cancer, General Medicine, Complete responses, Hematology/Oncology, Ipilimumab, n/a OA procedure, Adoptive cell therapy, Nivolumab, Ipilimumab/adverse effects, Immunotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edf28a71e5a16116e2b0f59cdac9485aTest
https://research.rug.nl/en/publications/9033fdbd-9e6f-4cca-a35b-50890da9f292Test

المؤلفون: Valesca P. Retèl, Lotte M. G. Steuten, Marnix H. Geukes Foppen, Janne C. Mewes, Melanie A. Lindenberg, John B. A. G. Haanen, Wim H. van Harten

المصدر: BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)

مصطلحات موضوعية: Tumor infiltrating lymphocytes, Ipilimumab, Advanced melanoma, Cost-effectiveness analysis, Coverage with evidence development, Personalized medicine, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

العلاقة: http://link.springer.com/article/10.1186/s12885-018-4788-5Test; https://doaj.org/toc/1471-2407Test; https://doaj.org/article/e50a67f8eb514c8f865b0a96c13e2530Test

الإتاحة: https://doi.org/10.1186/s12885-018-4788-5Test
https://doaj.org/article/e50a67f8eb514c8f865b0a96c13e2530Test

المؤلفون: Christian U. Blank, Johannes V. Van Thienen, Dieta Brandsma, John B. A. G. Haanen, Willem Boogerd, Marnix H Geukes Foppen

المصدر: Melanoma Research. 28:126-133

مصطلحات موضوعية: Adult, Male, Proto-Oncogene Proteins B-raf, Cancer Research, medicine.medical_specialty, Skin Neoplasms, Pyridones, medicine.medical_treatment, Pyrimidinones, Dermatology, Gastroenterology, Targeted therapy, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Oximes, medicine, Humans, 030212 general & internal medicine, Vemurafenib, Melanoma, Protein Kinase Inhibitors, Aged, Retrospective Studies, Aged, 80 and over, Trametinib, Brain Neoplasms, business.industry, Hazard ratio, Imidazoles, Retrospective cohort study, Dabrafenib, Middle Aged, MAP Kinase Kinase Kinases, medicine.disease, Radiation therapy, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, Mutation, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a56245b818de085dbed173af7f8d70cTest
https://doi.org/10.1097/cmr.0000000000000429Test

المؤلفون: Daniel S. Peeper, Christian U. Blank, Hans W.M. Niessen, Julia Boshuizen, Thomas Kuilman, Aida Shahrabi, Ji Ying Song, Xiangjun Kong, Kristel Kemper, Marnix H Geukes Foppen, Elisa A. Rozeman

المساهمون: CCA - Cancer biology and immunology, AGEM - Digestive immunity, ACS - Heart failure & arrhythmias, Amsterdam Neuroscience - Cellular & Molecular Mechanisms, Cardio-thoracic surgery, Pathology

المصدر: Nature, 550(7675), 270-274. Nature Publishing Group
Nature
Kong, X, Kuilman, T, Shahrabi, A, Boshuizen, J, Kemper, K, Song, J Y, Niessen, H W M, Rozeman, E A, Foppen, M H G, Blank, C U & Peeper, D S 2017, ' Cancer drug addiction is relayed by an ERK2-dependent phenotype switch ', Nature, vol. 550, no. 7675, pp. 270-274 . https://doi.org/10.1038/nature24037Test

مصطلحات موضوعية: 0301 basic medicine, Proto-Oncogene Proteins B-raf, Epithelial-Mesenchymal Transition, Lung Neoplasms, JUNB, MAP Kinase Signaling System, Dacarbazine, Antineoplastic Agents, Biology, Pharmacology, Receptor tyrosine kinase, Article, 03 medical and health sciences, Mice, Cell Line, Tumor, medicine, Animals, Humans, Epithelial–mesenchymal transition, Molecular Targeted Therapy, Melanoma, Gene Editing, Mice, Knockout, Mitogen-Activated Protein Kinase 1, Microphthalmia-Associated Transcription Factor, Multidisciplinary, Cell Death, medicine.disease, Microphthalmia-associated transcription factor, 3. Good health, 030104 developmental biology, Phenotype, Drug Resistance, Neoplasm, Cancer cell, biology.protein, Female, CRISPR-Cas Systems, Reprogramming, medicine.drug, Transcription Factors

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df46b5ac7614ee892024f1d1e15da0caTest
https://doi.org/10.1038/nature24037Test

المؤلفون: Christian U. Blank, Michele Maio, Michael A. Postow, Benjamin Weide, Phillip Wong, Dirk Schadendorf, Anna Maria Di Giacomo, Florian Heubach, Jianda Yuan, Paolo A. Ascierto, Amir Khammari, Marnix H Geukes Foppen, Brigitte Dréno, Graham Pawelec, Claus Garbe, Emanuela Romano, Domenico Mallardo, Bastian Schilling, Jedd D. Wolchok, Kilian Wistuba-Hamprecht, Alexander Martens

المساهمون: Department of Dermatology [Tubingen, Germany], University Medical Center [Tubingen, Germany], Department of Internal Medicine II [Tübingen, Germany], University Medical Center [Tübingen, Germany], Immunité et cancer (U932), Université Paris Descartes - Paris 5 (UPD5)-Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM), The Netherlands Cancer Institute [Amsterdam, The Netherlands], Memorial Sloane Kettering Cancer Center [New York], Weill Medical College of Cornell University [New York], Istituto Nazionale Tumori Fondazione Pascale [Naples, Italy], Department of Dermatology [Essen, Germany], University Hospital [Essen, Germany]-West German Cancer Center [Essen, Germany]-University Duisburg-Essen [Germany], German Cancer Consortium [Heidelberg] (DKTK), Division of Medical Oncology and Immunotherapy [Siena, Italy], University Hospital of Siena, Centre de Recherche en Cancérologie Nantes-Angers (CRCNA), Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM)-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Laennec-Centre National de la Recherche Scientifique (CNRS)-Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes (CHU Nantes), School of Science and Technology [Nottingham, U.K.], Nottingham Trent University, Division of Cancer Studies [London, UK], King‘s College London, Parts of this study were funded by Bristol-Myers Squibb (Munich, Germany) to B Weide. Parts of this study were funded by the EU Seventh Framework Program ‘PRIAT’ (Profiling Responders In Antibody Therapies) grant agreement no 305309 to C Garbe. Parts of this study were funded by Deutsche Forschungsgemeinschaft DFG PA 361-22/1 to G. Pawelec., European Project: 305309,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,PRIAT(2012), Bernardo, Elizabeth, Profiling Responders In Antibody Therapies - PRIAT - - EC:FP7:HEALTH2012-11-01 - 2014-10-31 - 305309 - VALID, Immunité et cancer ( U932 ), Université Paris Descartes - Paris 5 ( UPD5 ) -Institut Curie-Institut National de la Santé et de la Recherche Médicale ( INSERM ), Memorial Sloan Kettering Cancer Center [New York, NY, USA], Weill Cornell Medical College [New York, NY, USA], German Cancer Consortium - DKTK [Heidelberg, Germany], Centre de Recherche en Cancérologie / Nantes - Angers ( CRCNA ), CHU Angers-Hôtel-Dieu de Nantes-Institut National de la Santé et de la Recherche Médicale ( INSERM ) -Hôpital Laennec-Centre National de la Recherche Scientifique ( CNRS ) -Faculté de Médecine d'Angers-Centre hospitalier universitaire de Nantes ( CHU Nantes ), Nottingham Trent University [U.K.], European Project : 305309,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,PRIAT ( 2012 ), Universität Duisburg-Essen = University of Duisburg-Essen [Essen]-University Hospital [Essen, Germany]-West German Cancer Center [Essen, Germany]

المصدر: European Journal of Cancer
European Journal of Cancer, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. 〈10.1016/j.ejca.2016.12.011〉
European Journal of Cancer, Elsevier, 2017, 73, pp.61-70. ⟨10.1016/j.ejca.2016.12.011⟩

مصطلحات موضوعية: CD4-Positive T-Lymphocytes, Male, 0301 basic medicine, Oncology, Cancer Research, Skin Neoplasms, Programmed Cell Death 1 Receptor, Medizin, Kaplan-Meier Estimate, CD8-Positive T-Lymphocytes, [ SDV.CAN ] Life Sciences [q-bio]/Cancer, 0302 clinical medicine, Biomarker, Effector memory cells, Ipilimumab, Melanoma, Prognosis, medicine.diagnostic_test, Effector, Antibodies, Monoclonal, Middle Aged, Flow Cytometry, Peripheral, 030220 oncology & carcinogenesis, Biomarker (medicine), Female, medicine.drug, Adult, medicine.medical_specialty, Antineoplastic Agents, [SDV.CAN]Life Sciences [q-bio]/Cancer, Peripheral blood mononuclear cell, Article, Flow cytometry, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Antigens, Neoplasm, Internal medicine, Biomarkers, Tumor, medicine, Humans, Aged, business.industry, medicine.disease, 030104 developmental biology, Immunology, business, Immunologic Memory, CD8

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88a6982f18635313131b596d20ee2f8dTest
https://doi.org/10.1016/j.ejca.2016.12.011Test

المؤلفون: Melanie Lindenberg, Wim H. van Harten, Valesca P. Retèl, John B. A. G. Haanen, Joost H. van den Berg, Marnix H Geukes Foppen

المساهمون: Health Technology & Services Research

المصدر: Journal of Immunotherapy (Hagerstown, Md. : 1997)
Journal of Immunotherapy, 41(9), 413-425. Lippincott Williams and Wilkins

مصطلحات موضوعية: 0301 basic medicine, Adult, Cancer Research, medicine.medical_specialty, Technology Assessment, Biomedical, Health Personnel, Immunology, MEDLINE, Pharmacist, UT-Hybrid-D, malignant melanoma, chemical and pharmacologic phenomena, Pilot Projects, Immunotherapy, Adoptive, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Lymphocytes, Tumor-Infiltrating, Randomized controlled trial, law, Stakeholder Participation, Surveys and Questionnaires, Clinical Studies, Immunology and Allergy, Medicine, Humans, Medical physics, Product (category theory), Melanoma, Reimbursement, Pharmacology, business.industry, Technician, hemic and immune systems, Health Care Costs, Middle Aged, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, tumor-infiltrating lymphocytes, translational medical research, ComputingMethodologies_DOCUMENTANDTEXTPROCESSING, advanced therapy medicinal product, ATMP, business, Knowledge transfer, adoptive immunotherapy

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d4a7b685f125c616ec3d01d4749c6b1Test
https://pubmed.ncbi.nlm.nih.gov/30300260Test

المؤلفون: Wim H. van Harten, Janne C. Mewes, Marnix H Geukes Foppen, Lotte Maria Gertruda Steuten, Valesca P. Retèl, John B. A. G. Haanen, Melanie Lindenberg

المساهمون: Health Technology & Services Research

المصدر: BMC Cancer, Vol 18, Iss 1, Pp 1-11 (2018)
BMC cancer, 18(1):895. BioMed Central

مصطلحات موضوعية: Oncology, Male, Cancer Research, medicine.medical_specialty, Cost effectiveness, Cost-Benefit Analysis, Denmark, Ipilimumab, Expected value of perfect information, lcsh:RC254-282, Disease-Free Survival, Value of information, 03 medical and health sciences, 0302 clinical medicine, Lymphocytes, Tumor-Infiltrating, Internal medicine, Genetics, medicine, Humans, 030212 general & internal medicine, Melanoma, Netherlands, Coverage with evidence development, business.industry, Cost-effectiveness analysis, Antibodies, Monoclonal, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Advanced melanoma, Personalized medicine, Tumor infiltrating lymphocytes, Clinical trial, Models, Economic, 030220 oncology & carcinogenesis, Economic evaluation, Female, Immunotherapy, Quality-Adjusted Life Years, business, Progressive disease, medicine.drug

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e1c975559dbbf7e956f2fb5704ff458Test
https://doi.org/10.1186/s12885-018-4788-5Test

المؤلفون: Christian U. Blank, Marieke A Peters, Marianne B. Crijns, Marnix H Geukes Foppen

المصدر: Journal of Cancer Research and Therapeutics. 16:170

مصطلحات موضوعية: Neuroblastoma RAS viral oncogene homolog, business.industry, Melanoma, Viral Oncogene, virus diseases, Imiquimod, General Medicine, medicine.disease_cause, medicine.disease, Oncology, Neuroblastoma, medicine, Cancer research, Radiology, Nuclear Medicine and imaging, KRAS, HRAS, skin and connective tissue diseases, business, Vemurafenib, neoplasms, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::4ca332f1d792273b95fd41a0eec86d1cTest
https://doi.org/10.4103/jcrt.jcrt_317_17Test

المؤلفون: David W. Vredevoogd, David Satijn, Marnix H Geukes Foppen, Elisa A. Rozeman, Aida Shahrabi, Jens Thing Mortensen, Thomas Kuilman, Julia Boshuizen, Christian U. Blank, Elke Gresnigt-van den Heuvel, Nora Pencheva, Oscar Krijgsman, Daniel S. Peeper, Louise A. Koopman, Esther C.W. Breij, Paul W. H. I. Parren, Kristel Kemper, Ji-Ying Song, Maarten L. Janmaat, Maarten A. Ligtenberg

المصدر: Nature Medicine, 24(2), 203

مصطلحات موضوعية: 0301 basic medicine, MAPK/ERK pathway, Proto-Oncogene Proteins B-raf, Antibody-drug conjugate, Immunoconjugates, Combination therapy, Cell, General Biochemistry, Genetics and Molecular Biology, Receptor tyrosine kinase, 03 medical and health sciences, Genetic Heterogeneity, Mice, In vivo, Cell Line, Tumor, Proto-Oncogene Proteins, medicine, Animals, Humans, Melanoma, Protein Kinase Inhibitors, biology, Chemistry, Receptor Protein-Tyrosine Kinases, General Medicine, medicine.disease, Xenograft Model Antitumor Assays, Axl Receptor Tyrosine Kinase, 030104 developmental biology, medicine.anatomical_structure, Drug Resistance, Neoplasm, biology.protein, Cancer research, Antibody, Oligopeptides

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ff1dd468b21966ffd7a2decddea84f3Test
https://hdl.handle.net/1887/96424Test